Document is current
Any future updates will be listed below
-
Authors
Heilmeier, U.
Cheng, K.
Pasco, C.
Parrish, R.
Nirody, J.
Patsch, J. M.
Zhang, C. A.
Joseph, G. B.
Burghardt, A. J.
Schwartz, A. V.
Link, T. M.
Kazakia, G.
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH RC1 AR058405, NIH R01 AR06700)
Erwin Schrödinger grant (J-3079)
QUEST scholarship program
University of Berkeley Undergraduate Research Apprentice Program
- License Information
-
More Information
Article History
Received: 2 October 2015
Accepted: 20 April 2016
First Online: 6 May 2016
Compliance with ethical standards
:
: Dr. Burghardt serves as consultant for Ultragenyx Pharmaceutical Inc., and Dr. Link received grant money from NIH-NIAMS. Dr. Heilmeier received travel funds from ASBMR. Karen Cheng, Robin Parrish, Jasmine Nirody, Janina M. Patsch, Chiyuan A. Zhang, Gabby B. Joseph, Ann V. Schwartz, and Galateia Kazakia declare that they have no conflict of interest.
